Vincerx Pharma Inc (NASDAQ:VINC) has a beta value of 1.58 and has seen 1.77 million shares traded in the recent trading session. The company, currently valued at $0.88M, closed the recent trade at $0.17 per share which meant it lost -$0.11 on the day or -38.55% during that session. The VINC stock price is -11594.12% off its 52-week high price of $19.88 and -29.41% below the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.03 million shares traded. The 3-month trading volume is 1.15 million shares.
The consensus among analysts is that Vincerx Pharma Inc (VINC) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Vincerx Pharma Inc (NASDAQ:VINC) trade information
Sporting -38.55% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the VINC stock price touched $0.17 or saw a rise of 42.63%. Year-to-date, Vincerx Pharma Inc shares have moved -96.78%, while the 5-day performance has seen it change -38.68%. Over the past 30 days, the shares of Vincerx Pharma Inc (NASDAQ:VINC) have changed -76.50%. Short interest in the company has seen 0.14 million shares shorted with days to cover at 0.1.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 94.33% from the levels at last check today.. The projected low price target is $2.0 while the price target rests at a high of $4.0. In that case, then, we find that the latest price level in today’s session is -2252.94% off the targeted high while a plunge would see the stock gain -1076.47% from the levels at last check today..
Vincerx Pharma Inc (VINC) estimates and forecasts
The company’s shares have lost -97.91% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -146.76% over the past 5 years.
VINC Dividends
Vincerx Pharma Inc is expected to release its next earnings report on 2025-Mar-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vincerx Pharma Inc (NASDAQ:VINC)’s Major holders
Insiders own 4.11% of the company shares, while shares held by institutions stand at 4.06% with a share float percentage of 4.24%. Investors are also buoyed by the number of investors in a company, with Vincerx Pharma Inc having a total of 25.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.63 million shares worth more than $0.51 million. As of 2024-06-30, VANGUARD GROUP INC held 2.932% of shares outstanding.
The other major institutional holder is PROSIGHT MANAGEMENT, LP, with the holding of over 2.49 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.02 million and represent 0.0162% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.27% shares in the company for having 14.02 shares of worth $3855.0 while later fund manager owns 7.08 shares of worth $1946.0 as of Feb 28, 2025 , which makes it owner of about 0.14% of company’s outstanding stock.
